Eloxx Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview

Eloxx Pharmaceuticals

04/11/2022 19:35

* Eloxx Pharmaceuticals Inc  ELOX.OQ   ELOX.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 7 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Eloxx
Pharmaceuticals Inc
is for a loss of 11 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Eloxx
Pharmaceuticals Inc is $3​, above​ its last closing price
of $0.15. ​​​

This summary was machine generated November 4 at 19:35 GMT.  All
figures in US dollars  unless otherwise stated